US Patent

US9687465 — Compositions for the treatment of rosacea

Method of Use · Assigned to Sol Gel Technologies Ltd · Expires 2032-11-27 · 7y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects pharmaceutical compositions for topical use in treating skin conditions such as rosacea.

USPTO Abstract

The present invention relates to pharmaceutical compositions for topical use (including also dermatological compositions), for treating skin conditions and afflictions, such as rosacea and symptoms and conditions associated there from.

Drugs covered by this patent

Benzamycin (BENZOYL PEROXIDE) · Mayne Pharma

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3356`	—	Benzamycin

Patent Metadata

Patent number: US9687465
Jurisdiction: US
Classification: Method of Use
Expires: 2032-11-27
Drug substance claim: No
Drug product claim: Yes
Assignee: Sol Gel Technologies Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.